Skip to main content

Mitochondrial Medicine Program News

Our team of world-renowned experts are focused on determining the best course of treatment for each patient while working with your primary care physician, neurologist and other specialists.

Appointments and referrals

Researchers at Children’s Hospital of Philadelphia Highlight Benefits of Proton Therapy for Pediatric Hodgkin Lymphoma Patients

Oct 8, 2024

A new study from Children’s Hospital of Philadelphia (CHOP) showed promising results for Pediatric Hodgkin Lymphoma (pHL) patients who underwent proton therapy to treat their disease in rare regions located below the diaphragm, such as the abdomen and pelvis. The study highlights the advantages of proton therapy over conventional photon radiotherapy, demonstrating fewer side effects and better protection for critical organs. It was published recently in the journal Pediatric Blood and Cancer.

Jump back to top